Literature DB >> 8808600

Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.

V Biancalana1, L Taine, J C Bouix, S Finck, A Chauvin, H De Verneuil, S J Knight, C Stoll, D Lacombe, J L Mandel.   

Abstract

The original test for the analysis of the CCG expansion at the FRAXE locus involves Southern blot analysis of HindIII digests. We show that, by using a different probe, the FRAXE mutation can be detected easily on the same EcoRI or EagI+EcoRI blots as are used for detection of FRAXA. Unexpectedly, we found that both the expansion and methylation status can be determined on a single EcoRI digest, because of the presence of a methylation-sensitive EcoRI site very close to the CCG repeat. We thus detected in a series of mentally retarded individuals previously tested for FRAXA expansion a FRAXE proband who led to the identification of a large sibship (7 of 10 children carrying a mutation). We also show that two fragile X families without FRAXA mutation that previously have been described by Oberlé et al. have the FRAXE expansion. In another family also ascertained initially by cytogenetic finding of a fragile X site, we performed the combined cytogenetic and molecular prenatal diagnosis of a mutated male fetus. All nine males (>3 years old) in whom we found a methylated mutation had mild mental retardation. Our results suggest that the threshold of repeat length for abnormal methylation and fragile-site expression may be smaller at FRAXE than at FRAXA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808600      PMCID: PMC1914785     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  FRAXE expansion is not a common etiological factor among developmentally delayed males.

Authors:  D J Allingham-Hawkins; P N Ray
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

2.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.

Authors:  G A Flynn; M C Hirst; S J Knight; J N Macpherson; J C Barber; A V Flannery; K E Davies; V J Buckle
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

3.  The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter.

Authors:  R J Ritchie; S J Knight; M C Hirst; P K Grewal; M Bobrow; G S Cross; K E Davies
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

4.  Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE.

Authors:  J E Parrish; B A Oostra; A J Verkerk; C S Richards; J Reynolds; A S Spikes; L G Shaffer; D L Nelson
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap.

Authors:  S J Knight; M A Voelckel; M C Hirst; A V Flannery; A Moncla; K E Davies
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

6.  Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data.

Authors:  B C Hamel; A P Smits; E de Graaff; D F Smeets; F Schoute; B H Eussen; S J Knight; K E Davies; C F Assman-Hulsmans; B A Oostra
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

7.  Identification of the gene FMR2, associated with FRAXE mental retardation.

Authors:  J Gecz; A K Gedeon; G R Sutherland; J C Mulley
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

8.  Three families with high expression of a fragile site at Xq27.3, lack of anomalies at the FMR-1 CpG island, and no clear phenotypic association.

Authors:  I Oberlé; J Boué; M F Croquette; M A Voelckel; M G Mattei; J L Mandel
Journal:  Am J Med Genet       Date:  1992 Apr 15-May 1

9.  The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE.

Authors:  M C Hirst; A Barnicoat; G Flynn; Q Wang; M Daker; V J Buckle; K E Davies; M Bobrow
Journal:  Hum Mol Genet       Date:  1993-02       Impact factor: 6.150

10.  FRAXE and mental retardation.

Authors:  J C Mulley; S Yu; D Z Loesch; D A Hay; A Donnelly; A K Gedeon; P Carbonell; I López; G Glover; I Gabarrón
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

View more
  4 in total

1.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

Review 2.  Instability and chromatin structure of expanded trinucleotide repeats.

Authors:  Vincent Dion; John H Wilson
Journal:  Trends Genet       Date:  2009-06-18       Impact factor: 11.639

3.  EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders.

Authors:  Valérie Biancalana; Dieter Glaeser; Shirley McQuaid; Peter Steinbach
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 4.  RNA biology of disease-associated microsatellite repeat expansions.

Authors:  Kushal J Rohilla; Keith T Gagnon
Journal:  Acta Neuropathol Commun       Date:  2017-08-29       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.